Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.
Conagra and General Mills are among the food companies offering special options for people on GLP-1 drugs, but the products ...
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results